The Global Proton Pump Inhibitors (PPI) Market is a cornerstone of the pharmaceutical industry, providing essential therapeutic solutions for chronic and acute acid-related gastrointestinal (GI) disorders. According to the market analysis, the sector commanded a valuation of USD 3.45 Billion in 2024, firmly positioning it as a mature yet rapidly expanding segment. The forward-looking assessment...